Business Context and Reporting Period
Company: Gentex Corporation (GNTX)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: Gentex designs and manufactures digital vision and connected car products, premium audio equipment, and biometric solutions. The period includes the full impact of the VOXX International Corporation acquisition (closed April 1, 2025) and the BioConnect acquisition (closed July 1, 2025).
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $675.4 million | $576.8 million |
| Gross Profit | $228.6 million | $191.7 million |
| Gross Margin | 33.8% | 33.2% |
| Operating Income | $123.7 million | $113.0 million |
| Net Income (Attributable to Gentex) | $98.5 million | $94.9 million |
| Diluted EPS | $0.46 | $0.42 |
| Cash from Operations | $137.1 million | $148.5 million |
| Cash & Equivalents (End of Period) | $164.8 million | $286.6 million |
| Short-term Debt | $3.8 million | $3.8 million |
| Working Capital | $763.6 million | $740.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% ($98.7 million) year-over-year. This includes $88.6 million in revenue from the VOXX acquisition. Excluding VOXX, "Core Gentex" revenue grew 2% despite a 3% decline in global light vehicle production.
- Operating Expenses: Increased to $105.0 million from $78.7 million. The $26.3 million increase was primarily driven by the inclusion of VOXX ($23.2 million) and a $2.8 million impairment charge on In-Process R&D assets (Vaporsens).
- Other Income/Loss: Shifted from a net income of $0.6 million in Q1 2025 to a net loss of $5.6 million in Q1 2026. This was driven by a $2.7 million impairment on a technology investment, a $2.2 million increase in credit loss reserves, and lower investment income.
- Share Repurchases: The company repurchased 3.3 million shares for approximately $68.6 million during the quarter.
Guidance, Outlook, and Risks
2026 Full-Year Guidance (Updated April 24, 2026)
- Consolidated Revenue: $2.65 billion – $2.75 billion (Raised from $2.60B – $2.70B).
- Gross Margin: 34% – 35% (No change).
- Operating Expenses: $410 million – $420 million (Excluding severance and impairments; No change).
- Tax Rate: 16% – 18% (No change).
- Capital Expenditures: $125 million – $140 million (No change).
Outlook and Risks
- Production Forecast: Global light vehicle production is forecast to decline 2% in Q2 2026 and 2% for the full year 2026 compared to 2025.
- Tariff Uncertainty: The U.S. Supreme Court struck down certain IEEPA tariffs, but a new 10% global tariff was announced. The company estimates $15 million of IEEPA tariff costs are capitalized in inventory. Potential refunds are not recognized due to uncertainty regarding timing and amount.
- Impairments: The company recorded a $2.8 million impairment on Vaporsens In-Process R&D due to cost overruns and delays, and a $2.7 million impairment on a technology investment.
- Market Risks: Ongoing risks include trade wars, geopolitical conflicts (Iran, Ukraine, Israel-Hamas), supply chain constraints, and customer pricing pressure.
Investor Verification Checklist
- VOXX Integration: Verify the sustainability of the $88.6 million revenue contribution from VOXX and the integration of its premium audio brands (Klipsch, Onkyo, Integra).
- Tariff Impact: Monitor the resolution of the new 10% global tariff and the status of potential refunds for previously paid IEEPA tariffs ($42 million cumulative paid).
- Impairment Trends: Assess if the $5.5 million in total impairments (R&D and Technology Investments) signals broader issues in the company's non-core R&D pipeline or investment portfolio.
- Core Automotive Volume: Confirm that the 2% organic growth in core automotive revenue can be maintained despite the forecasted 2-3% decline in global light vehicle production.
- Cash Flow vs. Capital Allocation: Review the balance between strong operating cash flow ($137.1M) and significant outflows for share repurchases ($68.6M) and dividends ($25.9M).